Piper Sandler initiated coverage on shares of Myriad Genetics (NASDAQ:MYGN – Free Report) in a research note released on Thursday morning, Benzinga reports. The firm issued a neutral rating and a $23.00 price target on the stock. A number of other analysts have also weighed in on MYGN. StockNews.com upgraded shares of Myriad Genetics from […]
Myriad Genetics (NASDAQ:MYGN – Get Free Report) issued an update on its FY 2023 earnings guidance on Thursday morning. The company provided EPS guidance of -0.330–0.280 for the period, compared to the consensus EPS estimate of -0.300. The company issued revenue guidance of $747.0 million-$753.0 million, compared to the consensus revenue estimate of $750.9 million. […]
Myriad Genetics (NASDAQ:MYGN) Earns Equal Weight Rating from Analysts at Wells Fargo & Company themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Myriad Genetics (NASDAQ:MYGN – Get Free Report) issued an update on its FY 2023 earnings guidance on Thursday morning. The company provided EPS guidance of -0.330–0.280 for the period, compared to the consensus EPS estimate of -0.300. The company issued revenue guidance of $747.0 million-$753.0 million, compared to the consensus revenue estimate of $750.9 million. […]
Myriad Genetics (NASDAQ:MYGN) Shares Gap Up to $19 05 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.